Embed
Email

UNIVERSITY OF MIAMI

Document Sample

Shared by: linzhengnd
Categories
Tags
Stats
views:
1
posted:
11/14/2011
language:
English
pages:
9
UNIVERSITY OF MIAMI

Curriculum Vitae





DATE: 6/8/08



I. PERSONAL



2. Name: Juan Pablo Zambrano. MD. FACC

3. Cell Phone: Private

4. Office Phone: 305 585 7561

5. Home Address: Private

Work: 1120 NW 12th St. Suite 1110, Miami, FL, 33136

6. Current Academic Rank: Assistant Professor

6a. Current Track of Appointment: clinical track

7. Primary Department: Medicine

8. Secondary or Joint Appointments: Cardiology, Interventional Cardiology for

UM/JMH/VAMC

9. Citizenship: US Citizen



II. HIGHER EDUCATION

6/1995-6/1997 Social Service at The Instituto de Cardiologia Alfredo Palacio,

Guayaquil, Ecuador

5/1994-5/1995 Externship at University of Miami (Ob-Gyn, Surgery, Pediatrics

and Internal Medicine) through the J.W. Harrington Latin

American Training Program

5/1987-5/1995 Medical School: Universidad Catolica Santiago de Guayaquil,

Guayaquil, Ecuador

5/1981-5/1987 Middle and High School: Colegio Jesuita Javier, Guayaquil,

Ecuador

5/1975-1/1981 Elementary School: Colegio Salesiano Cristobal Colon, Guayaquil,

Ecuador



Postdoctoral training

7/2004-7/2005 Interventional Cardiology Fellowship: University of Miami,

Jackson Memorial Hospital, VAMC, Miami, Florida

7/2001-6/2004 Cardiology Fellowship: University of Miami, Jackson Memorial

Hospital, VAMC, Miami, Florida

6/2000-6/2001 Medical Chief Resident: VAMC, University of Miami, Miami,

Florida

7/1997-6/2000 Internship and Residency: University of Miami, Jackson Memorial

Hospital, VAMC, Miami, Florida

Licensure/Certification

Florida License ME80831

Internal Medicine Board Certified 2001

Nuclear Cardiology License

Cardiology Board Certified 2005

Nuclear Cardiology Board Certified 2005

ACLS/BLS Certified 2008

Interventional Cardiology Board Certification 2006





III. EXPERIENCE



2/2007-Present Assistant Professor of Medicine, Division of CardioVascular

Medicine, Cardiovascular Interventionalist and Stem Cell Research

Institute Member

7/2005-2/2007 Garcia & Pastoriza PA Cardiology Group. Clinical and

Interventional Cardiology at Kendall Regional Medical Center,

Baptist Hospital and South Miami Hospital. Miami, Florida





8/2004-6/2005 Intensive Care Unit physician at Memorial West Hospital.

Pembroke Pines, Florida

1/2003-6/2004 Intensive Care Unit physician at Memorial Regional Hospital.

Hollywood, Florida

10/2000-6/2005 Intensive Care Unit physician at West Palm Beach VA, Florida

10/2000-10/2004 Emergency Room physician at the Miami VA, Florida

6/2000-6/2001 Ward Attending for Internal Medicine at the Miami VA, Florida

5/1995-5/1997 Cardiology Resident at Instituto Nacional de Cardiologia Alfredo

Palacio (INCAP), Guayaquil, Ecuador

IV. PUBLICATIONS



(1) Published Papers in Peer Reviewed Journals

 Evaluation of comorbidity scores to predict all-cause mortality in patients with

established coronary artery disease. Int J Cardiol. 2006 Jul 11 Chirinos JA,

Veerani A, Zambrano JP, Schob A, Perez G, Mendez AJ, Chakko S.

 Is TEE useful in patients with small subcortical strokes? Eur J Neurol. 2006

May;13(5):522-7.. Rabinstein AA, Chirinos JA, Fernandez FR, Zambrano JP.

 Ability of serum to decrease cellular acylCoA:cholesterol acyl transferase activity

predicts cardiovascular outcomes.Circulation. 2005 Oct 18;112(16):2446-53.

Chirinos JA, Zambrano JP, Chakko SC, Schob A, Goldberg RB, Perez GO,

Mendez AJ.

 Relation between ascending aortic pressures and outcomes in patients with

angiographically demonstrated coronary artery disease.Am J Cardiol. 2005 Sep

1;96(5):645-8. Chirinos JA, Zambrano JP, Chakko S,; Veerani A, Schob A;

Perez G, Mendez A.

 Correlation between apoptotic endothelial microparticles and serum interleukin-6

and C-reactive protein in healthy men. Am J Cardiol. 2005 May 15;95(10):1258-

60. Chirinos JA; Zambrano JP; Jimenez J; Jy W; Virani S, MD; Ahn E,

Horstman LL; Castellanos A Myerburg RJ; Ahn YS.

 Aortic pressure augmentation predicts adverse cardiovascular events in patients

with established coronary artery disease.Hypertension. 2005 May;45(5):980-5.

Julio A. Chirinos JA, Zambrano JP, Chakko S,; Veerani A, Schob A; Perez G,

Mendez A.

 Usefulness of C-Reactive Protein (CRP) is an independent predictor of death in

Patients with Ischemic Cardiomyopathy. Submitted to American Journal of

Cardiology2005;95(1):88-90. Chirinos JA, Zambrano JP, Chakko S, Schob A,

Veerani A, Perez GO, Mendez AJ.

 Elevation of Endothelial Microparticles, platelet and leukocyte activation in

patients with Venous Thromboembolism. JACC 2005;45:1467-71. Julio A.

Chirinos, MD; Gustavo A. Heresi, MD; Hermes Velasquez, MD; Wenche Jy,

PhD; Joaquin J. Jimenez, MD; Eugene Ahn, MD; Lawrence L. Horstman, BS;

Andres O. Soriano, MD; Juan P. Zambrano, MD; Yeon S. Ahn, MD

 Digoxin use is associated with increased platelet and endothelial cell activation in

patients with non-valvular atrial fibrillation. Heart Rhythm 2005;2:525-529. Julio

A. Chirinos, MD; Aurelio Castrellon, MD; Zambrano JP, MD; Wenche Jy, PhD,

Larry Horstman, MS; Joaquin Jiménez, MD; Howard Wellens, MD; Agustin

Castellanos, MD Robert J. Myerburg; MD; Yeon Ahn, MD

 Body mass index is not a risk factor for unstable angina and myocardial infarction

in veteran patients with angiographically confirmed coronary artery disease.

Circulation. 2004 May 11;109(18):e215-6. Chirinos JA, Zambrano JP, Veerani

A.

 Noncompaction of the Ventricular Myocardium: The Use of Contrast-Enhanced

Echocardiography in Diagnosis. Journal of the American Society of

Echocardiography 2003 Jan; 16: 94-96. Lowery MH, Martel JA, Zambrano JP,

Ferreira A, Eco L, Gallagher A.

 Images in cardiovascular medicine: Left bundle-branch block with technical right-

axis deviation. Circulation. 2002 Oct 22;106(17):2288-9. Castellanos A, Pastor

JA, Zambrano JP, Myerburg RJ.·

 Percutaneous stenting of bilateral pulmonary artery stenosis caused by malignant

extrinsic compression. Chest. 2002 Oct;122(4):1478-80. Fierro-Renoy C,

Velasquez H, Zambrano JP, Ridha M, Kessler K, Schob A.

 Mechanical Reperfusion during Acute Myocardial Infarction in a Patient with

Dextrocardia. Journal of Invasive Cardiology.. Zambrano JP, De la Hera, De

Marchena E.

 Platelet Activation Promotes Formation Of Platelet-Leukocyte Conjugates (PLC)

In Non-Valvular Atrial Fibrillation (AF). Blood . In Press. Castrellon A, Chirinos

JA, Zambrano JP, Jy W, Horstmann LL, Ahn ER, Jimenez JJ, Willens H,

Castellanos A, Myerburg RJ, Ahn YS







(2) Texbook Chapters

 Is hs-CRP Ready for "Prime Time" As A Prognostic Risk Factor For

Cardiovascular Disease? Editorial, Hurst The Heart (Web Page) Chapter 38:

Dyslipidemia, other Risk Factors, and the Prevention of Coronary Heart Disease.

2003. Zambrano JP, Munoz O, O’Rourke R

 Endothelial Function Chapter 6, Interventional Cardiology Secrets, Hanley and

Belfus Inc (An Imprint of Elsevier) 2003

 Stages of Coronary Atherosclerosis Chapter 7, Interventional Cardiology Secrets,

Hanley and Belfus Inc (An Imprint of Elsevier) 2003







(3) Published Abstracts

 Carotid Artery Stenting Registry in High-risk Patients with Carotid Stenosis -

Miami Veterans Administration Hospital Experience. Submitted TCT 08

Abstract. Alfonso, Carlos E.; Toledo, Yeraldine; Pascual, Mario; Bhatt, Mehul;

Diaz, Miguel A.; Zambrano, Juan Pablo; Reyes-Iglesias, Yolanda; Schob, Alan.

Department of Medicine, Division of Cardiology, University of Miami Miller

School of Medicine Miami, Florida, Miami Veterans Administration Hospital

Miami, Florida.



 The Impact Of Intravenous Allogeneic Human Mesenchymal Stem Cells

(Provacel™) On Ejection Fraction In Patients With Myocardial Infarction. Circ.

2007; A1014. Zambrano J, Traverse J, Henry T, Dib N, Strumpf R, Schulman S,

Gerstenblith G, DeMaria A, Denktas A, Gammon R, Hermiller J, Reisman M,

Schaer G, Sherman W, Tamariz L, Hare J.



 Cardiac Chimerism Following Intramyocardial Mesenchymal Stem Cell

Transplantation. JACC 2007. Hatzistergos K, Quevedo H, Oskouei B, Zambrano

J, Qinghua H, Mazhari R, Helman A, McNiece I,Hare J.



 Mesenchymal Stem Cell Therapy Restores Cardiac Stem Cell Niches alter Acute

Myocardial Infarction. Circ. Res. 2007; 101;1204-11 A 4016.Chatzistergos K,

Quevedo H, Oskouei B, Qinghua H, Mazhari R, Revilla C, Zambrano J,

McNiece I, Heldman A, Hare J. Stem Cell Institute, Div of Cardiology UM Miller

School of Medicine.

 Correlation between apoptotic endothelial microparticles and Subclinical

Inflammation in healthy individuals. Journal of the American College of

Cardiology. ACC 44 Meeting. March 2005. Chirinos JA; Zambrano JP; Jimenez

J; Jy W; Virani S, MD; Ahn E, Horstman LL; Castellanos A Myerburg RJ; Ahn

YS.

 Digoxin use is associated with increased platelet and endothelial cell activation in

patients with non-valvular atrial fibrillation. Journal of the American College of

Cardiology. ACC 44 Meeting. March 2005. Julio A. Chirinos, MD; Aurelio

Castrellon, MD; Zambrano JP, MD; Wenche Jy, PhD, Larry Horstman, MS;

Joaquin Jiménez, MD; Howard Wellens, MD; Agustin Castellanos, MD Robert J.

Myerburg; MD; Yeon Ahn, MD

 Elevation of Endothelial Microparticles, platelet and leukocyte activation in

patients with Venous Thromboembolism. Journal of the American College of

Cardiology. ACC 44 Meeting. March 2005. Julio A. Chirinos, MD; Gustavo A.

Heresi, MD; Hermes Velasquez, MD; Wenche Jy, PhD; Joaquin J. Jimenez, MD;

Eugene Ahn, MD; Lawrence L. Horstman, BS; Andres O. Soriano, MD;

Zambrano JP, MD; Yeon S. Ahn, MD

 C-Reactive Protein (CRP) is an independent predictor of death in Patients with

Cardiomyopathy. Heart Failure Society of America Meeting 2004. Chirinos JA,

Zambrano JP, Chakko S, Schob A, Veerani A, Perez GO, Mendez AJ.

 High-density Lipoprotein-Mediated cholesterol efflux from cells is a strong

independent predictor of cardiovascular risk. Journal of the American College of

Cardiology. ACC 43 (5). March 2004: 463A. Chirinos JA, Zambrano JP,

Chakko SC, Schob A, Perez GO, Mendez AJ.

 Digoxin use is associated with increased platelet and endothelial cell activation in

patients with non-valvular atrial fibrillation. Heart Rhythm. 2004 May;27(S5).

Chirinos JA, Castrellon A, Zambrano JP, Willens H, Castellanos A, Myerburg

RJ, Ahn YS

 Elevated Endothelial Microparticles (EMP) and Activation Markers of Platelets

and Leukocytes in Venous Thromboembolism (VTE). Blood 102 (11), November

16, 2003. Heresi GA, Chirinos JA, Velasquez H, Zambrano JP, Soriano AO,

Horstman LL, Jy W, Ahn YS.

 Is TEE useful in patients with small subcortical strokes?. Neurology 62(S5):

A173. Rabinstein AA, Chirinos JA, Fernandez FR, Zambrano JP

 C-Reactive Protein and The Prediction of Cardiovascular Events in Patients with

Documented Coronary Artery Disease: Effects of Aspirin and Statin Therapy.

Journal of Investigative Medicine 2004 Jan; 52 (1): A25. Zambrano JP, Chirinos

JA, Tamariz LJ, Palacio A, Chakko S, Schob A, Perez GO, Mendez AJ.

 Correlation of High Sensitivity C-Reactive Protein with The Severity and Extent

of Coronary Artery, Presented at Florida Chapter of the ACC, Young

Investigator Competition. FCACC Newsletter 2001 Zambrano JP, Chirinos JA,

Hermes Flores, Chakko S, Schob A, Perez GO, Mendez AJ



(4)Miscellaneous





Other Abstracts

 Carotid Artery Stenting Registry in High-risk Patients with Carotid Stenosis -

Miami Veterans Administration Hospital Experience. Miami International

Revascularization Summit (MIRS) April 2008, Miami Beach, Fl. Alfonso, Carlos

E.; Toledo, Yeraldine; Pascual, Mario; Bhatt, Mehul; Diaz, Miguel A.;

Zambrano, Juan Pablo; Reyes-Iglesias, Yolanda; Schob, Alan. Department of

Medicine, Division of Cardiology, University of Miami Miller School of

Medicine Miami, Florida, Miami Veterans Administration Hospital Miami,

Florida.



 Allogeneic Mesenchymal Stem Cell therapy in a chronic model of myocardial

infarction. Presented at the 1st Clinical Disease Forum Annual Meeting at UM

Miller School of Medicine 2008, Miami, Fl. Hatzistergos K, Quevedo H, Oskouei

B, Zambrano J, Qinghua H, Mazhari R, Helman A, McNiece I,Hare J

 Mesenchymal stem cell transplantation after acute myocardial infarction:

Mechanisms of cardiac repair. Presented at the International Society of Cellular

Therapy 2008, Miami, Fl. Hatzistergos K, Quevedo H, Oskouei B, Zambrano J,

Qinghua H, Helman A, McNiece I,Hare J

 Influence of TEE in the Treatment of Important Sources of Emboli in Acute

Stroke, Presented at the Research Scholarly Activity Program of Internal

Medicine Dept. 1999 Zambrano JP, Andrade S, Bauerlein Joseph

 Myocardial Perfusion imaging in Coronary Disease in Patients with Combined

RBBB and LAFB, Presented in the Scientific Assembly and Annual Meeting of

the radiological Society of North America, Chicago, Illinois, 1995. Ezudin S,

Zambrano JP

 Assessment of the of the Immunocompromised Patient, Presented at the Nuclear

Oncology Congress: Advances in diagnostic and therapeutic applications, Key

Biscayne 1995 Ganz W, Zambrano JP

 Use of Viabahn Stent-grafts as an Adjunct to Superficial Femoral Artery

Angioplasty for Limb Salvage. Miami International Revascularization Summit

(MIRS) Feb 2005. Kenneth Zelnick, Hassan Tehrani, Alan Schob, Pranay

Ramdev, Zambrano JP, Cesar Jara, Darwin Eton.

 Serum-mediated intracellulat efflux cholesterol activity predicts cardiovascular

outcomes. Finalist Session, Young Investigator Awards Comptetition. Annual

Meeting of the Florida Chapter of the American College of Cardiology.

September 17-19, 2004. Miami, Florida. Chirinos JA, Zambrano JP, Chakko SC,

Schob A, Perez GO, Mendez AJ:





Presented outside USA

At the National Congress of Cardiology, Guayaquil, Ecuador 1995

 Prevalence of ASA in 357 Pts with Congenital Heart Disease. Transesophageal

echocardiography

 Correlation between Signal Average ECG and Left Ventricular Mass in Patients

with Hypertension

 Carotid Artery Evaluations in Patients with Cardiac and Neurologic abnormalities

 Efficacy of TEE in the Detection of Intracardiac Thrombi Missed by

Transthoracic Echocardiography







At the South American Congress of Cardiology, Quito, Ecuador 1993

 Patent Ductus Arteriosus in Guayaquil I Study

 Profile and frequency of Tetralogy of Fallot in 375 Children with Congenital

Hearth Diseases

 The Ventricular Septal Defects of the Guayaquil I Study

 Distribution of Congenital Heart Disease in the Guayaquil I Study

 The Atrial Septal Defect in the Congenital Heart Disease Population of the

Guayaquil I Study

 Cardiac Involvement in Systemic Hypertension and Aging

 Is the Age a Coronary Risk Factors

 Risk Factors and Ischemic Heart Disease Before and After the Age of 50

 Consequences and Risks of Left Ventricular Hypertrophy

 Primary Pericardial Lymphoma: Case Report



University Journal

 The amazing endothelium. Revista INCAP, Biannual publication 1998

 What happens to the Myocardial Cells during ischemia? Meta Cientifica

(University Journal) 1:3 1991

 Molecular Mechanisms of the cathecolamines. Meta Cientifica (University

Journal) 1:2 1990





V. PROFESSIONAL AND TEACHING



2008- Organizer of the First International Cardiovascular Conferences University of

Miami Miller School of Medicine and Universidad Espiritu Santo in Guayaquil-Ecuador

2008- Team Leader for the Creation of the University of Miami Cardiology Consult

Service

2007-8- Cardiology Grand Rounds Cardiovascular division, UM Miller School of

Medicine: Clinical Approach to Peripheral Vascular Disease

2008- Lecturer for the Cardiovascular System Module for freshman medical students UM

Miller School of Medicine, Topic: Peripheral Vascular Disease

2008 to Present- Co-Director of the 6th Annual MIRS (Miami International

Revascularization Summit)

2007 to Present- Establishment of Multidisciplinary Vascular Meetings Bi monthly at the

VAMC with the participation of Cardiovascular Medicine, Vascular Surgery, Wound

Care, Podiatry and Prevention of Amputation Team for case review and discussion

2007 to Present- Weekly Interventional Cardiology Conferences

2007 to Present- Committee of interview for new recruits in the Division of

CardioVascular Medicine.

2007 to Present- Development of the CardioVascular Peripheral Interventional Program

within the Division of CardioVascular Medicine for UM/JMH/VAMC

2007 to Present-Research in Myocardial Regeneration using Mesenchymal Stem Cells in

large animal models (porcine model) and human research (Co-Investigator for

Prometheus and

2007 to Present- Part of the STEMI Alert Team for JMH and VAMC

2007-Fellow of the American College of Cardiology (F.A.C.C)

2007- Invited speaker to Jornadas Medicas Internacionales Universidad Catolica Santiago

de Guayaquil, Ecuador

2006- Invited speaker to Jornadas de Atherosclerosis, Sociedad Ecuatoriana de

Cardiologia

2004-Best Cardiology Fellow in the Departement of Cardiology, University of Miami,

Florida

2002-Best Subspecialty Fellow in the Department of Medicine, University of Miami,

Florida

2001-Finalist in Young Investigator Award at the Florida Chapter of The ACC

2000-ACP/ASIM Chief Medical Resident Award

1995-1996 Instructor Assistant in Cardiology Courses, Universidad Catolica Santiago de

Guayaquil, Ecuador

1991-1993 Winner of Contest for Instructor in Parasitology and Mycology, Universidad

Catolica Santiago de Guayaquil, Ecuador



Doctoral Thesis: “Specificity of Thallium Stress Test in Patients With RBBB and LAH”

Trainned in Peripheral Endovascular Therapy during Interventional Fellowship at

JMH/VAMC



Related docs
Other docs by linzhengnd
i-Health
Views: 0  |  Downloads: 0
State employees recall events of September 11
Views: 7  |  Downloads: 0
0804050421330_2110
Views: 4  |  Downloads: 0
Listino2009 - Meetup
Views: 0  |  Downloads: 0
TwoSurveyCalculator
Views: 0  |  Downloads: 0
Guidelines.xlsx
Views: 0  |  Downloads: 0
APPALACHIA AND THE OZARKS
Views: 2  |  Downloads: 0
Proliferation Studies
Views: 0  |  Downloads: 0
By registering with docstoc.com you agree to our
privacy policy

You are almost ready to download!

You are almost ready to download!